28^th Annual Summit on Neuroscience & Neurological Disorders April 25-26, 2022 Barcelona, Spain

Leontino Battistin, M.D. Professor of Neurology Past Director, Dept of Neurosciences, University of Padova, Italy Past Vice President of the World Federation of Neurology

Neurology

Ljudmila Stojanovich received her Ph.D. in Medicine, with the thesis “Neuropsychiatric manifestations in patients with Systemic Lupus Erythematosus” in 1999. She is the scientific director in the Bezhanijska Kosa,

NEUROPSYCHIATRIC MANIFESTATIONS IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASE

Specialist for Spinal surgery, Head and cerebral neurosurgery, Neurosurgical Spine Surgery in Berlin

Spinal surgery, Head and cerebral neurosurgery, Neurosurgical Spine Surgery

Dr. Danilov is a system neuroscientist with over 40 years’ experience in research on brain functions and the special senses, including vision, taste, hearing and balance. He was a Senior Scientist and Director of Clinical Research at Wicab, Inc., where as co-inventor oversaw both conceptual development for the BrainPort vision and balance systems

Neuroplasticity, Neurorehabilitation, Enhancement of human performance

Human Perfomance, Human Movement Anatomy, PhD in Neuroscience, Research Psicology,Traumatology & Orthopedic, Project Manager , Strength and Conditioning specialist Physical Therapy, Skynesiology and Spinology, Exercise Physiology, Spa Therapist Physiology, Support Health Worker, aesthetic medical, sports masseur, expert in postural gymnastics, psychology and psychomotion for the elderly and special children or with learning disabilities.

Human Movement Anatomy, Neuroscience, Research Psicology, Traumatology & Orthopedic

Mr. Cheung Chun Luke is the president of Eaulier(Dalian) Hospital. His research interests are focus on Degenerative Brain Diseases such as Parkinson’s Disease, Alzheimer’s Disease. Cerebellar atrophy. Autism. Stroke sequelae.

Degenerative Brain Diseases such as Parkinson’s Disease, Alzheimer’s Disease, Cerebellar atrophy, Autism, Stroke sequelae

Mirela Olympia Fagarasan Palmer works in academia as an internationally recognized neuropharmacology and neuroimmunology researcher. She published more than 500 scientific reports in the field of neuropsychopharmacology and signal transduction. She is leading a laboratory interested in understanding the fundamental neurobiological mechanisms of neuropsychiatric disorders to contribute at development of new pharmacological treatments. Uses genetic, neuroendocrine and neurochemical methods. She recognized the role of the immune system in modulating neuropsychiatric diseases and we are developing in vitro cellular models and in vivo animal models to study the neuro-immune interactions under normal and disease states. She has successfully combined research, teaching, administration and clinical care and continue to work on advancing and understanding the cause of serious mental illness.

Neuropsychopharmacology, Aging,Alzheimer's Disease, Neurodegeration, Regeneration, Signal Transduction.

RNDr. Nadezda Lukacova, DrSc. has 30 years of research experience in the field of neurobiology. She published more than 80 CC papers, which were cited 687-times, edited 1 book, and contributed to 10 book chapters published in Plenum Press, Nova Science Publishers, Elsevier, Transworld Research Network, and Human Press. Currently, she is a member of the editorial board of the international scientific journal General Physiology & Biophysics. In the analytical ARRA project "Identification of the top research teams and their members to SAS", her research team was rated as "above average scientific team" in 2011

Neurological Disorder

Mr. De la Parra-Solomon is an entrepreneur focused on Mental Health. Mr. De la Parra-Solomon is the Chief Strategy Officer and Co-Founder of the Quantum Brain Research Institute (www.quantumbrain.institute), a HealthTech initiative established in Tallinn, Estonia focused on Mental Health and Information Technology solutions.

Mental health